Wall St set for $1bn fee bonanza from pharma mega-deal
Bristol-Myers Squibb and Celgene $90bn merger ranks among most lucrative for banks
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Mergers and Aquisitions | Pharmaceuticals